ZyVersa Therapeutics, Inc. has received a notice of delisting from Nasdaq due to its securities closing at less than $1.00 per share for ten consecutive trading days.
AI Assistant
ZYVERSA THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.